CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	IPO [Member]	Private Placement [Member]	Convertible Preferred Stock	Common Stock	Common Stock IPO [Member]	Common Stock Private Placement [Member]	Additional Paid-In Capital	Additional Paid-In Capital IPO [Member]	Additional Paid-In Capital Private Placement [Member]	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning Balance at Dec. 31, 2020	$ (8,413)				$ 1			$ 208				$ (8,622)
Beginning Balance of Temporary Equity, Shares at Dec. 31, 2020				4,422,350
Beginning Balance of Temporary Equity, Value at Dec. 31, 2020				$ 9,667
Beginning Balance, Shares at Dec. 31, 2020					1,432,480
Issuance of common stock	349				$ 1			348
Issuance of common stock, Shares					336,575
Exercise of common stock options	1							1
Exercise of common stock options, Shares					506
Issuance of Series A-1 convertible preferred stock, net of issuance costs of $33				$ 12,467
Issuance of Series A-1 convertible preferred stock, net of issuance cost, shares				5,321,132
Issuance of Series A-1 convertible preferred stock related to settlement of preferred stock tranche rights				$ 368
Issuance of Series A-1 convertible preferred stock related to settlement of preferred stock tranche rights, Shares				161,324
Issuance of Series B convertible preferred stock, net of issuance costs of $247				$ 99,753
Issuance of Series B convertible preferred stock, net of issuance cost, Shares				17,521,047
Issuance of Series B convertible preferred stock related to settlement of anti-dilution right				$ 263
Issuance of Series B convertible preferred stock related to settlement of anti-dilution right, Shares				46,058
Stock-based compensation expense	497							497
Net loss	(16,243)											(16,243)
Ending Balance at Dec. 31, 2021	$ (23,809)				$ 2			1,054				(24,865)
Ending Balance of Temporary Equity, Shares at Dec. 31, 2021	27,471,911			27,471,911
Ending Balance of Temporary Equity, Value at Dec. 31, 2021	$ 122,518			$ 122,518
Ending Balance, Shares at Dec. 31, 2021					1,769,561
Issuance of common stock		$ 96,169	$ 4,650			$ 9			$ 96,160	$ 4,650
Issuance of common stock, Shares						8,585,540	400,000
Exercise of common stock options	$ 24							24
Exercise of common stock options, Shares	25,039				25,039
Conversion of convertible preferred stock to common stock, Shares				(27,471,911)	11,140,262
Conversion of convertible preferred stock to common stock	$ 122,518			$ (122,518)	$ 11			122,507
Unrealized loss on available-for-sale investments, net of tax	(95)										$ (95)
Stock-based compensation expense	2,185							2,185
Net loss	(31,167)											(31,167)
Ending Balance at Dec. 31, 2022	$ 170,475				$ 22			$ 226,580			$ (95)	$ (56,032)
Ending Balance, Shares at Dec. 31, 2022					21,920,402